Abstract
Microbial transformation studies can be used as models to simulate mammalian drug metabolism. In the present investigation, biotransformation of celecoxib was studied in microbial cultures. Bacterial, fungal, and yeast cultures were employed in the present study to elucidate the metabolism of celecoxib. The results indicate that a number of microorganisms metabolized celecoxib to various levels to yield eight metabolites, which were identified by high-performance liquid chromatography diode array detection and liquid chromatography tandem mass spectrometry analyses. HPLC analysis of biotransformed products indicated that majority of the metabolites are more polar than the substrate celecoxib. The major metabolite was found to be hydroxymethyl metabolite of celecoxib, while the remaining metabolites were produced by carboxylation, methylation, acetylation, or combination of these reactions. The methyl hydroxylation and further conversion to carboxylic acid was known to occur in metabolism by mammals. The results further support the use of microorganisms for simulating mammalian metabolism of drugs.
Similar content being viewed by others
References
Smith, R. V., & Rosazza, J. P. (1975). Journal of Pharmaceutical Sciences, 11, 1737–1759.
Smith, R.V. and Rosazza, J.P. (1982) In J. P. Rosazza (Ed.), Microbial transformations of bioactive compounds (pp.1–42). Boca Raton: CRC
Smith, R. V., & Rosazza, J. P. (1983). Journal of Natural Products, 46, 79–91.
Clark, A. M., McChesney, J. D., & Hufford, C. D. (1985). Medicinal Research Reviews, 5, 231–253.
Clark, A. M., & Hufford, C. D. (1991). Medicinal Research Reviews, 11, 473–501.
Abourashed, E. A., Clark, A. M., & Hufford, C. D. (1999). Current Medicinal Chemistry, 6, 359–374.
Ferris, J. P., MacDonald, L. H., Patrie, M. A., & Martin, M. A. (1976). Archives of Biochemistry and Biophysics, 175, 443–452.
Venisetty, R. K., & Ciddi, V. (2003). Current Pharmaceutical Biotechnology, 4, 123–140.
Paulson, S. K., Hribar, J. D., Liu, N. W. K., Hajdu, E., Bible, R. H., Jr., Piergies, A., et al. (2000). Drug Metabolism and Disposition, 28, 308–314.
Paulson, S. K., Zhang, J. Y., Breau, A. P., Hribar, J. D., Liu, N. W. K., Jessen, S. M., et al. (2000). Drug Metabolism and Disposition, 28, 514–521.
Backhus, L. M., Petasis, N. A., Uddin, J., Schonthal, A. H., Bart, R. D., Lin, Y., et al. (2005). J. Journal of Thoracic and Cardiovascular Surgery, 130, 1406–1412.
Pyrko, P., Soriano, N., Kardosh, A., Liu, Y. T., Uddin, J., Petasis, N. A., et al. (2006). Mol. Cancer, 5, 19.
Abbate, F., Coetzee, A., Casini, A., Ciattini, S., Scozzafava, A., & Supuran, C. T. (2004). Bioorganic & Medicinal Chemistry Letters, 14, 337–341.
Solomon, S.D., McMurray, J.J.V., Pfeffer, M.A., Wittes, J., Fowler, R., Finn, P., Anderson, W.F., Zauber, A., Hawk, E. and Bertagnolli, M. (2005) New Eng. J. Med. 352, 1071–1080.
Venisetty, R. K., Keshetty, S., & Ciddi, V. (2004) Abstract 64th International Pharmaceutical Federation Congress, New Orleans, p. 16.
Jayasagar, G., Kumar, M. K., Chandrasekhar, K., Prasad, P. S., & Rao, Y. M. (2002). Pharmazie, 57, 619–621.
Cha, C. J., Doerge, D. R., & Cerniglia, C. E. (2001). Applied and Environmental Microbiology, 67, 4358–4360.
Zhang, D., Evans, F. E., Freeman, J. P., Yang, Y., Deck, J., & Cerniglia, C. E. (1996). Chemico-Biological Interactions, 102, 79–92.
Duhart, B. T., Zhang, D., Deck, J., Freeman, J. P., & Cerniglia, C. E. (1999). Xenobiotica, 29, 733–746.
Hansen, E. B., Jr., Heflich, R. H., Korfmacher, W. A., Miller, D. W., & Cerniglia, C. E. (1988). Journal of Pharmaceutical Sciences, 77, 259–264.
Zhang, J. Y., Wang, Y. F., Dudkowski, C., Yang, D., Chang, M., Yuan, J., et al. (2000). Journal of Mass Spectrometry, 35, 1259–1270.
Otten, S., & Rosazza, J. P. (1981). Journal of Natural Products, 44, 562–568.
Sariaslani, F. S., & Rosazza, J. P. (1985). Applied and Environmental Microbiology, 49, 451–452.
Hufford, C. D., Lee, I. S., ElSohly, H. N., Chi, H. T., & Baker, K. T. (1990). Pharmaceutical Research, 7, 923–967.
Freitag, D. G., Foster, R. T., Coutts, R. T., Pickard, M. A., & Pasutto, F. M. (1997). Drug Metabolism and Disposition, 25, 685–692.
Huang, H., Yang, X., Li, Q., Sun, L., & Zhong, D. (2006). Applied Microbiology and Biotechnology, 72, 486–491.
Penning, T. D., Talley, J. T., Bertenshaw, S. R., Carter, J. S., Collins, P. W., Docter, S., et al. (1997). Journal of Medicinal Chemistry, 40, 1347–1365.
Sandberg, M., Yasar, U., Stromberg, P., Hoog, J. O., & Eliasson, E. (2002). British Journal of Clinical Pharmacology, 54, 423–429.
Schwartz, H., Liebig-Weber, A., Hochstätter, H., & Böttcher, H. (1996). Applied Microbiology and Biotechnology, 44, 731–735.
Mazier, C., Jaouen, M., Sari, M., & Buisson, D. (2004). Bioorganic & Medicinal Chemistry Letters, 14, 5423–5426.
Mountfield, R. J., & Hopper, D. J. (1998). Applied Microbiology and Biotechnology, 50, 379–383.
Rosi, D., Peruzotti, G., Dennis, E. W., Berberian, D. A., Freele, H., Tullar, B. F., et al. (1967). Journal of Medicinal Chemistry, 10, 867–876.
Schwartz, H., Licht, R. E., & Radunz, H. E. (1993). Applied Microbiology and Biotechnology, 40, 382–385.
Zhang, D., Zhang, H., Aranibar, N., Hanson, R., Huang, Y., Cheng, P. T., et al. (2006). Drug Metabolism and Disposition, 34, 267–280.
Clark, A. M., Hufford, C. D., & McChesney, J. D. (1981). Antimicrobial Agents and Chemotherapy, 19, 337–341.
Clark, A. M., Evans, S. L., Hufford, C. D., & McChesney, J. D. (1982). Journal of Natural Products, 45, 574–581.
Foster, G. R., Coutts, R. T., Pasutto, F. M., & Mozayani, A. (1988). Life Sciences, 42, 285–292.
Foster, B. C., Wilson, D. L., & McGilveray, I. J. (1989). Xenobiotica, 19, 445–452.
Foster, G. R., Lister, D. L., Zamecnic, J., & Coutts, R. T. (1991). Canadian Journal of Microbiology, 37, 791–795.
Wetzstein, H. G., Stadler, M., Tichy, H. V., Dalhoff, A., & Karl, W. (1999). Applied and Environmental Microbiology, 65, 1556–1563.
Parshikov, I. A., Freeman, J. P., Lay, J. O., Jr., Beger, R. D., Williams, A. J., & Sutherland, J. B. (1999). FEMS Microbiology Letters, 177, 131–135.
Pal, M., Madan, M., Padakanti, S., Pattabiraman, V. R., Kalleda, S., Vanguri, A., et al. (2003). Journal of Medicinal Chemistry, 46, 3975–3984.
Dirikolu, L., Lehner, A. F., Jacobs, J., Woods, W. E., Karpiesiuk, W., Harkins, J. D., Carter, W. G., Boyles, J., Hughes, C. G., Bosken, J. M., Holtz, C., Natrass, C., Fisher, M., Tobin, T. (2000) Proceedings of the 13th International Conference of Racing Analysts and Veterinarians, Cambridge, pp. 162–170.
Acknowledgments
The authors are thankful to Dr. Ramesh Mullangi and Mr. Raja Reddy Kallem, Discovery Research, Dr. Reddy’s Laboratories, Hyderabad for LC–MS/MS spectral analysis. The work was carried out with the financial assistance from University Grants Commission, New Delhi and Council of Scientific & Industrial Research, New Delhi.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srisailam, K., Veeresham, C. Biotransformation of Celecoxib Using Microbial Cultures. Appl Biochem Biotechnol 160, 2075–2089 (2010). https://doi.org/10.1007/s12010-009-8789-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-009-8789-3